Who can use Xagrid(Anagrelide)?

This section outlines the recommended dosage regimen and titration schedule.

Dosage Guidance

For adults, the initial dose is 0.5 mg administered four times daily or 1 mg twice daily. The starting dose for pediatric patients (aged 7 years and older) is 0.5 mg once daily. This starting dose must be maintained for at least one week before any titration. Subsequent dose adjustments are based on platelet count response, aiming for a target below 600,000/µL. The weekly dose increase must not exceed 0.5 mg per day. The maximum single dose is 2.5 mg, and the maximum total daily dose is 10 mg. Frequent monitoring of platelet counts is essential.

Anagrelide(Xagrid)
A platelet-reducing agent for treating thrombocythemia secondary to myeloproliferative neoplasms.
RELATED ARTICLES
Indications for Anagrelide (Agrylin)

Anagrelide (Agrylin) is a thrombocytopenic agent primarily used to treat thrombocythemia caused by...

Friday, October 17th, 2025, 13:46
Indications for Anagrelide (Agrylin)

Anagrelide (Agrylin) is a thrombocytopenic agent primarily indicated for the treatment of thrombocythemia caused by...

Wednesday, September 24th, 2025, 14:22
/ 1
2 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved